Works matching IS 09509232 AND DT 2011 AND VI 30 AND IP 27

Results: 10

p53 inhibits mRNA 3′ processing through its interaction with the CstF/BARD1 complex.

Published in:

Oncogene, 2011, v. 30, n. 27, p. 3073, doi. 10.1038/onc.2011.29

By:

Nazeer, F I;
Devany, E;
Mohammed, S;
Fonseca, D;
Akukwe, B;
Taveras, C;
Kleiman, F E

Publication type:

Article

Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib.

Published in:

Oncogene, 2011, v. 30, n. 27, p. 3084, doi. 10.1038/onc.2011.24

By:

Takahashi, F;
Chiba, N;
Tajima, K;
Hayashida, T;
Shimada, T;
Takahashi, M;
Moriyama, H;
Brachtel, E;
Edelman, E J;
Ramaswamy, S;
Maheswaran, S

Publication type:

Article

Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway.

Published in:

Oncogene, 2011, v. 30, n. 27, p. 3036, doi. 10.1038/onc.2011.33

By:

Thurber, A E;
Douglas, G;
Sturm, E C;
Zabierowski, S E;
Smit, D J;
Ramakrishnan, S N;
Hacker, E;
Leonard, J H;
Herlyn, M;
Sturm, R A

Publication type:

Article

OTX1 expression in breast cancer is regulated by p53.

Published in:

Oncogene, 2011, v. 30, n. 27, p. 3096, doi. 10.1038/onc.2011.31

By:

Terrinoni, A;
Pagani, I S;
Zucchi, I;
Chiaravalli, A M;
Serra, V;
Rovera, F;
Sirchia, S;
Dionigi, G;
Miozzo, M;
Frattini, A;
Ferrari, A;
Capella, C;
Pasquali, F;
Curto, F L;
Albertini, A;
Melino, G;
Porta, G

Publication type:

Article

From Rous sarcoma virus to plasminogen activator, src oncogene and cancer management.

Published in:

Oncogene, 2011, v. 30, n. 27, p. 3003, doi. 10.1038/onc.2011.38

By:

Sudol, M

Publication type:

Article

HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents.

Published in:

Oncogene, 2011, v. 30, n. 27, p. 3024, doi. 10.1038/onc.2011.21

By:

Palmieri, D;
Valentino, T;
D'Angelo, D;
De Martino, I;
Postiglione, I;
Pacelli, R;
Croce, C M;
Fedele, M;
Fusco, A

Publication type:

Article

The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO.

Published in:

Oncogene, 2011, v. 30, n. 27, p. 3062, doi. 10.1038/onc.2011.32

By:

Duque-Afonso, J;
Yalcin, A;
Berg, T;
Abdelkarim, M;
Heidenreich, O;
Lübbert, M

Publication type:

Article

TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.

Published in:

Oncogene, 2011, v. 30, n. 27, p. 3011, doi. 10.1038/onc.2011.18

By:

Anania, M C;
Sensi, M;
Radaelli, E;
Miranda, C;
Vizioli, M G;
Pagliardini, S;
Favini, E;
Cleris, L;
Supino, R;
Formelli, F;
Borrello, M G;
Pierotti, M A;
Greco, A

Publication type:

Article

TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression.

Published in:

Oncogene, 2011, v. 30, n. 27, p. 3049, doi. 10.1038/onc.2011.25

By:

Seux, M;
Peuget, S;
Montero, M P;
Siret, C;
Rigot, V;
Clerc, P;
Gigoux, V;
Pellegrino, E;
Pouyet, L;
N'Guessan, P;
Garcia, S;
Dufresne, M;
Iovanna, J L;
Carrier, A;
André, F;
Dusetti, N J

Publication type:

Article

OTX1 expression in breast cancer is regulated by p53.

Published in:

Oncogene, 2011, v. 30, n. 27, p. 3104, doi. 10.1038/onc.2011.206

By:

Terrinoni, A;
Pagani, I S;
Zucchi, I;
Chiaravalli, A M;
Serra, V;
Rovera, F;
Sirchia, S;
Dionigi, G;
Miozzo, M;
Frattini, A;
Ferrari, A;
Capella, C;
Pasquali, F;
Lo Curto, F;
Albertini, A;
Melino, G;
Porta, G

Publication type:

Article